Ascendis Pharma A/S Assets in EUR from Q4 2016 to Q4 2024

Taxonomy & unit
ifrs-full: EUR
Summary
Ascendis Pharma A/S quarterly Assets history and growth rate from Q4 2016 to Q4 2024.
  • Ascendis Pharma A/S Assets for the quarter ending December 31, 2024 was €1.18B, a 42.9% increase year-over-year.
Assets, Quarterly (EUR)
Assets, YoY Quarterly Growth (%)

Ascendis Pharma A/S Quarterly Assets (EUR)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 1.18B +354M +42.9% Dec 31, 2024 20-F 2025-02-12
Q3 2024 1.09B +221M +25.3% Sep 30, 2024 6-K 2024-11-14
Q1 2024 803M -164M -16.9% Mar 31, 2024 6-K 2024-05-02
Q4 2023 826M -264M -24.2% Dec 31, 2023 20-F 2025-02-12
Q3 2023 873M -400M -31.4% Sep 30, 2023 6-K 2023-11-07
Q2 2023 824M -503M -37.9% Jun 30, 2023 6-K 2023-09-05
Q1 2023 966M -411M -29.8% Mar 31, 2023 6-K 2023-04-27
Q4 2022 1.09B +4.82M +0.44% Dec 31, 2022 20-F 2024-02-07
Q3 2022 1.27B +68.2M +5.66% Sep 30, 2022 6-K 2022-11-02
Q2 2022 1.33B +475M +55.8% Jun 30, 2022 6-K 2022-08-10
Q1 2022 1.38B +412M +42.7% Mar 31, 2022 6-K 2022-05-11
Q4 2021 1.08B +105M +10.7% Dec 31, 2021 20-F 2023-02-16
Q3 2021 1.21B +159M +15.2% Sep 30, 2021 6-K 2021-11-10
Q2 2021 852M +291M +52% Jun 30, 2021 6-K 2021-08-27
Q1 2021 965M +344M +55.3% Mar 31, 2021 6-K 2021-05-27
Q4 2020 980M +303M +44.8% Dec 31, 2020 20-F 2022-03-02
Q3 2020 1.05B +311M +42.3% Sep 30, 2020 6-K 2020-11-12
Q2 2020 561M -207M -26.9% Jun 30, 2020 6-K 2020-08-27
Q1 2020 621M -141M -18.4% Mar 31, 2020 6-K 2020-05-19
Q4 2019 677M +358M +112% Dec 31, 2019 20-F 2021-03-10
Q3 2019 735M +400M +119% Sep 30, 2019 6-K 2019-11-18
Q2 2019 767M +398M +108% Jun 30, 2019 6-K 2019-08-28
Q1 2019 762M +397M +109% Mar 31, 2019 6-K 2019-05-30
Q4 2018 319M +108M +51.2% Dec 31, 2018 20-F 2020-04-03
Q3 2018 335M Sep 30, 2018 6-K 2018-11-28
Q2 2018 369M Jun 30, 2018 6-K 2018-08-29
Q1 2018 365M Mar 31, 2018 6-K 2018-05-30
Q4 2017 211M +20.9M +11% Dec 31, 2017 20-F 2019-04-03
Q4 2016 190M Dec 31, 2016 20-F 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.